Perrigo Company Announces The Appointment Of Industry Veteran To Executive Vice President And General Manager, Rx

  Perrigo Company Announces The Appointment Of Industry Veteran To Executive
                    Vice President And General Manager, Rx

PR Newswire

ALLEGAN, Mich., Dec. 4, 2012

ALLEGAN, Mich., Dec. 4, 2012 /PRNewswire/ --The Perrigo Company (Nasdaq:
PRGO;TASE) today announced the appointment of Douglas Boothe as Executive Vice
President and General Manager, Perrigo Pharmaceuticals, effective January
2013. Sharon Kochan, who previously held this position, has been managing the
business in the interim since accepting the newly created role of Executive
Vice President and General Manager, International in July 2012.


Perrigo's Chairman, President and CEO Joseph C. Papa stated, "I am excited to
welcome Doug to the Perrigo family. He brings to us more than 22 years of
leadership and proven business results in the pharmaceutical and consumer
industries. Doug will leverage his strategic perspective, executional
leadership and industry experience in our prescription pharmaceutical
business, ensuring that the strong growth and profitability we have enjoyed
will continue into the future, allowing us to bring more quality, affordable
products to market for patients."

Prior to joining Perrigo, Doug served as Chief Executive Officer of Actavis
Inc., where he was responsible for all aspects of the company's generics
business in North America and Latin America, including sales, marketing,
supply chain, quality, finance, legal, IT, regulatory affairs, human resources
and intellectual property. He also has served in strategic planning and
business development leadership roles for Alpharma Inc., Pharmacia Corporation
and Xerox Corporation. Doug has a Bachelor of Science Degree in Mechanical and
Aerospace Engineering from Princeton University and a Master of Business
Administration in Marketing Management and Strategic Planning from the
University of Pennsylvania's Wharton School of Business.

From its beginnings as a packager of generic home remedies in 1887, Perrigo
Company, based in Allegan, Michigan, has grown to become a leading global
provider of quality, affordable healthcare products. The Company develops,
manufactures and distributes over-the-counter ("OTC") and generic prescription
("Rx") pharmaceuticals, nutritional products and active pharmaceutical
ingredients ("API") and is the world's largest manufacturer of OTC
pharmaceutical products for the store brand market. Perrigo's mission is to
offer uncompromised "quality, affordable healthcare products", and it does so
across a wide variety of product categories primarily in the United States,
United Kingdom, Mexico, Israel and Australia, as well as certain other markets
throughout the world, including Canada, China and Latin America. Visit Perrigo
on the Internet (

Note: Certain statements in this press release are forward-looking statements
within the meaning of Section 21E of the Securities Exchange Act of 1934, as
amended, and are subject to the safe harbor created thereby. These statements
relate to future events or the Company's future financial performance and
involve known and unknown risks, uncertainties and other factors that may
cause the actual results, levels of activity, performance or achievements of
the Company or its industry to be materially different from those expressed or
implied by any forward-looking statements. In some cases, forward-looking
statements can be identified by terminology such as "may," "will," "could,"
"would," "should," "expect," "plan," "anticipate," "intend," "believe,"
"estimate," "predict," "potential" or other comparable terminology. The
Company has based these forward-looking statements on its current
expectations, assumptions, estimates and projections. While the Company
believes these expectations, assumptions, estimates and projections are
reasonable, such forward-looking statements are only predictions and involve
known and unknown risks and uncertainties, many of which are beyond the
Company's control. These and other important factors, including those
discussed under "Risk Factors" in the Company's Form 10-K for the year ended
June 30, 2012, as well as the Company's subsequent filings with the Securities
and Exchange Commission, may cause actual results, performance or achievements
to differ materially from those expressed or implied by these forward-looking
statements. The forward-looking statements in this press release are made only
as of the date hereof, and unless otherwise required by applicable securities
laws, the Company disclaims any intention or obligation to update or revise
any forward-looking statements, whether as a result of new information, future
events or otherwise.

SOURCE Perrigo Company

Contact: Arthur J. Shannon, Vice President, Investor Relations and
Communication, +1-269-686-1709,; Bradley Joseph, Senior
Manager, Investor Relations and Communication, +1-269-686-3373,
Press spacebar to pause and continue. Press esc to stop.